Paper8552591
Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.
Chang K and 1 other. Proc Natl Acad Sci U S A, 1996. Cited by 631 papers, by iCite.
Cite this record
ConductScience Library. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Papers, record 8552591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8552591
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Membrane Glycoproteins | Major topic |
| Ovarian Neoplasms | Major topic |
| Amino Acid Sequence | |
| Base Sequence | |
| Cell Adhesion Molecules | |
| Cloning, Molecular | |
| DNA, Complementary | |
| Female | |
| GPI-Linked Proteins | |
| Gene Expression | |
| Genes | |
| Glycosylphosphatidylinositols | |
| HeLa Cells | |
| Humans | |
| Mesothelin | |
| Molecular Sequence Data | |
| RNA, Messenger |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01051934 | A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma | Background | ClinicalTrials.gov | |
| NCT01445392 | SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma | Background | ClinicalTrials.gov |
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 271968 | DNA sequencing with chain-terminating inhibitors. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/271968 | PubMed |
| 2 | 6310399 | A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6310399 | PubMed |
| 3 | 2953793 | Removal of lymphocyte surface molecules with phosphatidylinositol-specific phospholipase C: effects on mitogen responses and evidence that ThB and certain Qa antigens are membrane-anchored via phosphatidylinositol. | J Immunol | 1987 | https://conductscience.org/library/papers/2953793 | PubMed |
| 4 | 3670292 | High-efficiency transformation of mammalian cells by plasmid DNA. | Mol Cell Biol | 1987 | https://conductscience.org/library/papers/3670292 | PubMed |
| 5 | 3313053 | Anchoring mechanisms for LFA-3 cell adhesion glycoprotein at membrane surface. | Nature | 1987 | https://conductscience.org/library/papers/3313053 | PubMed |
| 6 | 3313277 | An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. | Nucleic Acids Res | 1987 | https://conductscience.org/library/papers/3313277 | PubMed |
| 7 | 2152774 | Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease. | Cancer Res | 1990 | https://conductscience.org/library/papers/2152774 | PubMed |
| 8 | 1717147 | Folate-binding protein is a marker for ovarian cancer. | Cancer Res | 1991 | https://conductscience.org/library/papers/1717147 | PubMed |
| 9 | 1719635 | GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. | Science | 1991 | https://conductscience.org/library/papers/1719635 | PubMed |
| 10 | 1727378 | Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium. | Cancer Res | 1992 | https://conductscience.org/library/papers/1727378 | PubMed |
| 11 | 1755986 | Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors. | Curr Opin Immunol | 1991 | https://conductscience.org/library/papers/1755986 | PubMed |
| 12 | 1735605 | Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium. | Int J Cancer | 1992 | https://conductscience.org/library/papers/1735605 | PubMed |
| 13 | 1599018 | Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma. | Am J Surg Pathol | 1992 | https://conductscience.org/library/papers/1599018 | PubMed |
| 14 | 1351045 | Frequent expression of the tumor antigen CAK1 in squamous-cell carcinomas. | Int J Cancer | 1992 | https://conductscience.org/library/papers/1351045 | PubMed |
| 15 | 1498329 | Monoclonal antibody-based therapies of leukemia and lymphoma. | Blood | 1992 | https://conductscience.org/library/papers/1498329 | PubMed |
| 16 | 8150545 | Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line. | Int J Cancer | 1994 | https://conductscience.org/library/papers/8150545 | PubMed |
| 17 | 8027078 | Cleavage of pseudomonas exotoxin and diphtheria toxin by a furin-like enzyme prepared from beef liver. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8027078 | PubMed |
| 18 | 7536959 | Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. | Science | 1995 | https://conductscience.org/library/papers/7536959 | PubMed |
Cited by368
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 631 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42920992 | Epitope selection overcomes antigen shedding to enable effective CAR-M therapy in solid tumors. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/42920992 | PubMed |
| 42608511 | Cold and hot tumors: immunological determinants, cancer-immunity cycle dysregulation, and nanotechnology-driven therapeutic approaches. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42608511 | PubMed |
| 42591971 | Conformational epitope engagement by anti-MSLN ADC RC88 confers resistance to soluble mesothelin. | Antib Ther | 2026 | https://conductscience.org/library/papers/42591971 | PubMed |
| 42483566 | Near Infrared Photoimmunotherapy for Lung Cancer: Recent Development and Perspective. | Immunotargets Ther | 2026 | https://conductscience.org/library/papers/42483566 | PubMed |
| 42459653 | Engineering a juxtamembrane-targeting CAR T-cell against mesothelin: a novel binder resilient to shed antigen for enhanced efficacy against ovarian and pancreatic cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42459653 | PubMed |
| 42292493 | Evaluating mesothelin as an immunotherapeutic target for endogenous T cells. | Front Immunol | 2026 | https://conductscience.org/library/papers/42292493 | PubMed |
| 42279275 | The Role of Mesothelin in Gynecological Tumors and Its Significance in Targeted Therapies-A Review. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42279275 | PubMed |
| 42125244 | Mesothelin-Binding Peptide Inhibits Cell Migration and Enables Targeted Delivery of a Mitochondrial-Membrane-Damaging Peptide to Pancreatic Tumors. | Biomater Res | 2026 | https://conductscience.org/library/papers/42125244 | PubMed |
| 42106231 | Prognostic Significance of Inflammatory, Cellular, and Tumor-Specific Biomarkers in Patients With Pleural and Peritoneal Mesothelioma. | Clin Lung Cancer | 2026 | https://conductscience.org/library/papers/42106231 | PubMed |
| 42035221 | Generation of functional mesothelial cells from human iPSCs that restore peritoneal integrity in experimental peritoneal injury. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/42035221 | PubMed |
| 41994562 | Mesothelin biology and the evolving landscape of targeted immunotherapy. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/41994562 | PubMed |
| 41901346 | Radioimmunotherapy for Malignant Mesothelioma Targeting C-ERC/Mesothelin. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41901346 | PubMed |
| 41866035 | Mesothelin promotes acute myeloid leukemia progression through LYN-dependent signaling. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41866035 | PubMed |
| 41824794 | MSLN expression predicts a high risk of EMD in AML by promoting cell adhesion and metastasis via interaction with MUC16. | Blood Adv | 2026 | https://conductscience.org/library/papers/41824794 | PubMed |
| 41550974 | RO4, a high-affinity humanized antibody against the juxtamembrane region of mesothelin for targeted cancer therapy. | Antib Ther | 2026 | https://conductscience.org/library/papers/41550974 | PubMed |
| 41543488 | Preclinical development of mesothelin-targeting CAR T cells for the treatment of cholangiocarcinoma. | Hepatol Commun | 2026 | https://conductscience.org/library/papers/41543488 | PubMed |
| 41513618 | MSLN-mediated activation of EGFR-ERK1/2 signaling drives liver metastasis in breast cancer. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/41513618 | PubMed |
| 41400642 | Novel perspectives on MSLN-targeted cancer therapy: from molecular mechanisms to clinical translation. | Cancer Biol Ther | 2025 | https://conductscience.org/library/papers/41400642 | PubMed |
| 41335396 | Decoding the role of mesothelin in tumor dynamics and targeted treatment innovations. | Mol Biomed | 2025 | https://conductscience.org/library/papers/41335396 | PubMed |
| 41298776 | Comprehensive single-cell transcriptome landscape of metastatic colorectal cancer identifies budding-potential cells and their interactions with cancer-associated fibroblasts. | NPJ Precis Oncol | 2025 | https://conductscience.org/library/papers/41298776 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MSLN | 10232 | Swiss-Prot's references | https://conductscience.org/library/genes/10232 |
Source NCBI Gene
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | U40434 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8552591
GET https://conductscience.org/api/papers/v1/8552591/cited_by?page=2